SPA-Cys Long is a recombinant Staphylococcal Protein A (SPA) engineered with a C-terminal cysteine residue. This modification enables site-specific conjugation via thiol chemistry, enhancing utility in antibody purification and biochemical assays. Produced in Escherichia coli, it retains the five IgG-binding domains (E-D-A-B-C) of native SPA, ensuring high affinity for immunoglobulins .
SPA-Cys Long is a non-glycosylated polypeptide with 423 amino acids and a molecular mass of 46.7 kDa. The C-terminal cysteine is positioned outside the rigid IgG-binding domains, allowing flexibility for conjugation without compromising binding efficacy .
Property | Value/Description | Source |
---|---|---|
Molecular Weight | 46.7 kDa | |
Purity | >97% (SDS-PAGE, RP-HPLC) | |
Solubility | Reconstituted in sterile H₂O (>0.1 mg/mL) | |
Stability | Lyophilized: -18°C; Reconstituted: 2-7°C |
IgG-Binding Domains: Five regions (E-D-A-B-C) aligned in series for high-affinity binding to human, mouse, and rabbit IgG subclasses .
Cysteine Residue: Positioned at the C-terminus for covalent conjugation to solid supports or biomolecules .
SPA-Cys Long is expressed in E. coli using plasmids like pET-28b or pET-22b. Intracellular production yields higher monomeric content (critical for binding efficiency) compared to extracellular methods .
Cell Lysis: Sonication or enzymatic disruption of E. coli cells.
Chromatography: Nickel-affinity (His-tag variants) or ion-exchange purification .
Quality Control: SDS-PAGE (reducing/non-reducing), SE-HPLC, and Ellman’s reagent for free cysteine quantification .
SPA-Cys Long binds IgG subclasses via Fc regions, enabling:
Site-Specific Immobilization: Conjugation to epoxy-activated resins via C-terminal cysteine for antibody capture .
High Capacity: >90% binding efficiency for human IgG1, IgG2, and IgG4 .
Protein Labeling: Thiol-reactive probes (e.g., maleimides) for fluorescent or biotinylated tagging .
Biosensor Applications: Immobilized SPA-Cys Long on SPR chips for real-time IgG binding kinetics .
Metric | Intracellular | Extracellular |
---|---|---|
Monomeric Content | ~80% | ~40% |
Free Cysteine | 1.2 µmol/mg (Ellman’s) | 0.8 µmol/mg (Ellman’s) |
Epoxide Binding | 45% | 24% |
Adapted from SE-HPLC and Ellman’s reagent assays . |
Dimerization Risks: Extracellular production increases dimer formation due to oxidative disulfide bonds between cysteine residues .
Storage Stability: Lyophilized formulations require desiccation to prevent aggregation. Reconstituted samples degrade within 7 days at 4°C .
Alternative Conjugation: Lysine amines (pKa ~10.5) show poor reactivity with epoxides, necessitating engineered cysteine for efficient coupling .
SPA-Cys Long is a recombinant form of Staphylococcal Protein A (SpA) produced in E. coli expression systems. It is engineered as a single non-glycosylated polypeptide chain with a specific cysteine residue added to the C-terminus. Unlike native SpA from Staphylococcus aureus, SPA-Cys Long contains all five IgG-binding domains (E-D-A-B-C) aligned in series, comprising 423 amino acids with a molecular mass of 46.7 kDa .
The native SpA in S. aureus contains a YSIRK/GXXS signal peptide motif that directs it to septal membranes during secretion, whereas the recombinant SPA-Cys Long lacks this secretion pathway and is produced directly in the cytoplasm of E. coli . The critical difference is the C-terminal cysteine residue, which provides a specific site for directed coupling chemistry not present in the native protein.
The five IgG-binding domains (E-D-A-B-C) in SPA-Cys Long each contribute to the protein's ability to bind immunoglobulins with high affinity. Each domain consists of approximately 58-61 amino acids with a three-helix bundle structure.
Methodological considerations:
The strategic C-terminal cysteine in SPA-Cys Long enables site-directed immobilization through thiol chemistry. This approach provides significant advantages over random coupling methods.
Recommended protocol:
Prepare a thiol-reactive matrix (e.g., iodoacetyl-activated or maleimide-activated agarose)
Reduce SPA-Cys Long with a mild reducing agent (5-10 mM DTT) for 30 minutes at room temperature
Remove the reducing agent using a desalting column equilibrated with coupling buffer (typically phosphate buffer pH 7.0-7.5)
Immediately mix the reduced SPA-Cys Long with the activated matrix
Allow coupling to proceed for 2-4 hours at room temperature or overnight at 4°C
Block unreacted sites with 50 mM cysteine or glutathione
Wash extensively to remove non-covalently bound protein
This oriented coupling maximizes IgG binding capacity by ensuring all domains remain accessible, unlike random amine coupling which may compromise some binding sites .
Understanding domain-specific binding patterns is crucial for optimizing SPA-Cys Long applications.
Methodological approach:
Competitive binding analysis:
Pre-incubate SPA-Cys Long with varying concentrations of IgG fragments
Analyze displacement patterns using surface plasmon resonance (SPR)
Calculate binding constants for different subclasses and species
Domain-specific mutagenesis:
Create variants with selective mutations in specific domains
Compare binding profiles using isothermal titration calorimetry (ITC)
Quantify thermodynamic parameters to identify domain-specific contributions
Hydrogen-deuterium exchange mass spectrometry:
Map binding interfaces at amino acid resolution
Identify structural changes upon ligand binding
Determine domain-specific binding kinetics
This methodical approach provides valuable insights for researchers developing specialized affinity matrices or diagnostic tools .
Leaching of SPA-Cys Long from affinity supports represents a common challenge in protein purification applications.
Troubleshooting methodology:
Optimize coupling chemistry:
Ensure complete reduction of the C-terminal cysteine prior to coupling
Verify coupling efficiency using spectrophotometric analysis of unreacted protein
Consider using longer-chain crosslinkers to reduce steric hindrance
Employ multi-point attachment:
Utilize bifunctional crosslinkers that react with both the C-terminal cysteine and amine groups
Implement mild crosslinking conditions to maintain protein conformation
Validate the impact on binding capacity after multi-point attachment
Implement milder elution conditions:
Investigate pH gradient elution instead of low pH step changes
Test competitive elution using synthetic peptides based on Fc regions
Develop custom buffer systems containing chaotropic agents at low concentrations
These approaches significantly reduce leaching while maintaining functional binding capacity of SPA-Cys Long affinity matrices.
Monitoring structural integrity is essential for ensuring consistent performance of SPA-Cys Long in research applications.
Analytical approach:
Circular dichroism (CD) spectroscopy:
Monitor alpha-helical content (characteristic of SPA-Cys Long domains)
Compare spectra before and after experimental treatments
Quantify structural changes using spectral deconvolution algorithms
Fluorescence spectroscopy:
Track changes in intrinsic tryptophan fluorescence
Analyze shifts in emission maxima indicating altered tertiary structure
Implement thermal scanning to assess stability profiles
Size-exclusion chromatography with multi-angle light scattering:
Detect aggregation or fragmentation
Calculate precise molecular weight distributions
Monitor batch-to-batch consistency
These complementary techniques provide a comprehensive assessment of SPA-Cys Long structural integrity throughout research procedures.
SPA-Cys Long offers unique opportunities for developing advanced imaging tools in cellular biology research.
Implementation strategy:
Site-specific fluorophore conjugation:
Utilize the C-terminal cysteine for maleimide-activated fluorophore attachment
Optimize dye-to-protein ratio to minimize interference with binding
Characterize spectral properties before and after conjugation
Development of quantum dot conjugates:
Functionalize quantum dots with maleimide groups
Control conjugation stoichiometry through reaction conditions
Validate binding specificity using competitive assays
Creation of bifunctional imaging probes:
Conjugate SPA-Cys Long to nanoparticles containing multiple functionalities
Incorporate secondary detection modalities (MRI contrast agents, radioactive tracers)
Characterize particle size distribution and colloidal stability
These approaches leverage the unique structural features of SPA-Cys Long to create advanced imaging tools with multiple applications in cellular and molecular biology.
Understanding how SPA-Cys Long interactions affect antibody functionality is crucial for certain immunological applications.
Experimental design:
Complement activation assays:
Condition | SPA-Cys Long:IgG Ratio | C1q Binding (% of Control) | C3b Deposition (% of Control) |
---|---|---|---|
Control | 0:1 | 100 | 100 |
Low | 1:1 | 75-85 | 80-90 |
Medium | 5:1 | 40-60 | 50-70 |
High | 10:1 | 15-30 | 20-40 |
Fc receptor binding analysis:
Pre-incubate antibodies with varying concentrations of SPA-Cys Long
Measure binding to FcγR-expressing cells using flow cytometry
Quantify competitive inhibition constants for different receptor types
Antibody-dependent cellular cytotoxicity (ADCC) functional assays:
Assess NK cell activation in the presence of SPA-Cys Long-bound antibodies
Measure target cell lysis efficiency with increasing SPA-Cys Long concentrations
Correlate functional changes with structural alterations in the Fc region
This systematic approach provides critical information for researchers utilizing SPA-Cys Long in complex immunological systems.
Understanding the differences between recombinant SPA-Cys Long and natively secreted Protein A provides valuable insights for research applications.
Native SpA in S. aureus undergoes a complex secretion process involving:
Initial targeting to septal membranes via the YSIRK/GXXS signal peptide motif
Processing by SecA and SecDF chaperones during membrane translocation
Specific cleavage events in the signal peptide region
In contrast, SPA-Cys Long bypasses these bacterial processing steps and lacks the cell wall sorting signal. This fundamental difference results in:
Absence of bacterial post-translational modifications
Higher uniformity in protein structure
Defined C-terminal cysteine availability for coupling chemistry
Potential differences in glycosylation patterns affecting stability
Researchers should consider these structural differences when designing experiments that aim to mimic or study native SpA functions.
Preserving the structural integrity and functional activity of SPA-Cys Long requires careful attention to storage conditions.
Recommended storage parameters:
Buffer composition:
50 mM sodium phosphate or HEPES buffer, pH 7.2-7.4
150 mM NaCl to maintain ionic strength
Optional addition of 1-5 mM EDTA to chelate metal ions
Consider adding 0.02-0.05% sodium azide as a preservative for long-term storage
Temperature conditions:
Primary recommendation: Store at -80°C for extended periods (>6 months)
Working aliquots can be maintained at -20°C for 1-2 months
Avoid repeated freeze-thaw cycles (limit to <5)
Stabilizing additives:
Addition of 5-10% glycerol or sucrose as cryoprotectants
For lyophilized storage, include 1-2% mannitol or trehalose as bulking agents
Consider adding 1 mM DTT for solutions where the C-terminal cysteine must remain reduced
Stability monitoring protocol:
Implement routine SDS-PAGE analysis to detect degradation
Check binding activity using IgG affinity chromatography
Monitor aggregation state using dynamic light scattering
Following these guidelines ensures maximum retention of SPA-Cys Long activity for research applications.
The recombinant form of Staphylococcal Protein A, specifically the Cys Long Form, is a genetically engineered version of the native protein. This recombinant protein retains the essential properties of the native SPA, including its ability to bind to IgG antibodies. The Cys Long Form is characterized by the presence of five IgG-binding regions, which enhances its binding capacity and makes it particularly useful for antibody purification processes .
Recombinant Staphylococcal Protein A Cys Long Form is widely used in various applications, including:
The production of recombinant SPA involves the expression of the protein in a suitable host organism, such as Escherichia coli. The protein is then purified through a series of chromatographic techniques to ensure high purity and functionality. The Cys Long Form is often lyophilized to enhance its stability and shelf life .